| Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies G Šimić, M Babić Leko, S Wray, C Harrington, I Delalle, ... Biomolecules 6 (1), 6, 2016 | 694 | 2016 |
| Enhanced tonic GABAA inhibition in typical absence epilepsy DW Cope, G Di Giovanni, SJ Fyson, G Orbán, AC Errington, ML Lőrincz, ... Nature medicine 15 (12), 1392-1398, 2009 | 456 | 2009 |
| SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Neuropharmacology 38 (8), 1195-1205, 1999 | 319 | 1999 |
| Non-steroidal anti-inflammatory drugs in Parkinson's disease E Esposito, V Di Matteo, A Benigno, M Pierucci, G Crescimanno, ... Experimental neurology 205 (2), 295-312, 2007 | 281 | 2007 |
| Monoaminergic neuropathology in Alzheimer’s disease G Šimić, MB Leko, S Wray, CR Harrington, I Delalle, N Jovanov-Milošević, ... Progress in neurobiology 151, 101-138, 2017 | 263 | 2017 |
| Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study G Di Giovanni, P De Deurwaerdère, M Di Mascio, V Di Matteo, E Esposito, ... Neuroscience 91 (2), 587-597, 1999 | 261 | 1999 |
| Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and … G Di Giovanni, V Di Matteo, M Di Mascio, E Esposito Synapse 35 (1), 53-61, 2000 | 239 | 2000 |
| Essential thalamic contribution to slow waves of natural sleep F David, JT Schmiedt, HL Taylor, G Orban, G Di Giovanni, VN Uebele, ... Journal of Neuroscience 33 (50), 19599-19610, 2013 | 223 | 2013 |
| Serotonin in animal cognition and behavior J Bacqué-Cazenave, R Bharatiya, G Barrière, JP Delbecque, ... International journal of molecular sciences 21 (5), 1649, 2020 | 215 | 2020 |
| Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Brain research 865 (1), 85-90, 2000 | 207 | 2000 |
| Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies V Di Matteo, G Di Giovanni, M Pierucci, E Esposito Progress in brain research 172, 7-44, 2008 | 197 | 2008 |
| Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders V Di Matteo, M Pierucci, E Esposito, G Crescimanno, A Benigno, ... Progress in brain research 172, 423-463, 2008 | 183 | 2008 |
| Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications P De Deurwaerdère, G Di Giovanni Progress in neurobiology 151, 175-236, 2017 | 175 | 2017 |
| Serotonin–dopamine interaction: electrophysiological evidence G Di Giovanni, V Di Matteo, M Pierucci, E Esposito Progress in brain research 172, 45-71, 2008 | 160 | 2008 |
| Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens V Di Matteo, G Di Giovanni, M Di Mascio, E Esposito Neuropharmacology 37 (2), 265-272, 1998 | 157 | 1998 |
| International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function NM Barnes, GP Ahern, C Becamel, J Bockaert, M Camilleri, ... Pharmacological reviews 73 (1), 310-520, 2021 | 156 | 2021 |
| m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors G Di Giovanni, V Di Matteo, V La Grutta, E Esposito Neuroscience 103 (1), 111-116, 2001 | 154 | 2001 |
| T-pattern analysis for the study of temporal structure of animal and human behavior: a comprehensive review M Casarrubea, GK Jonsson, F Faulisi, F Sorbera, G Di Giovanni, ... Journal of neuroscience methods 239, 34-46, 2015 | 145 | 2015 |
| Role of serotonin in central dopamine dysfunction G Di Giovanni, E Esposito, V Di Matteo CNS neuroscience & therapeutics 16 (3), 179-194, 2010 | 144 | 2010 |
| Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures V Crunelli, ML Lőrincz, C McCafferty, RC Lambert, N Leresche, ... Brain 143 (8), 2341-2368, 2020 | 142 | 2020 |
Philippe De DeurwaerdereProfesseur Neurosciences et Neuropharmacologie, Institut des neurosciences cognitives etVerified email at u-bordeaux.fr
